-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to statistics, there are 55 million dementia patients in the world, of which 60%-80% are dementia caused by AD
Antibody drug group
failed clinical trials
▲ Source of the results of two phase 3 trials of aducanumab: Bojian official website
References:
1.
——List of recent popular activities——
▼On August 14, the application and future prospects of TCR-T cell therapy in the treatment of solid tumors
▼August 16, mRNA preparation & LNP packaging whole process process points and quality control strategy
▼August 29, Phase 2: Immunometabolism Analysis, Helping Cellular Immunotherapy